Navigation Links
Hormone Therapy Increases Odds of Ovarian Cancer
Date:7/14/2009

But risk remains low and decreases two years after stopping, study finds,,

TUESDAY, July 14 (HealthDay News) -- Women who take hormone replacement therapy or have taken it in the recent past have a higher risk of developing ovarian cancer, suggests new research.

In a large Danish study, compared to women who never took hormone replacement therapy, current users had a 38 percent increased risk of ovarian cancer and a 44 percent increased risk of epithelial ovarian cancer, which is cancer that begins on the outer lining of the ovary. The results were reported in the July 15 issue of the Journal of the American Medical Association.

The absolute risk for any one woman is still quite small, however. The researchers calculated that for every 8,300 women, hormone therapy would result in one extra case of ovarian cancer a year.

"Our study underlines previous evidence that postmenopausal hormones increase the risk of ovarian cancer," said the study's lead author, Lina Steinrud Morch of the gynecological clinic at the Rigshospitalet of Copenhagen University in Denmark. "The risk among women taking hormones was increased regardless of the duration of use, the formulation, the estrogen dose, regimen, progestin type or route of administration," she added.

And, although the absolute risk of ovarian cancer remained low, Morch noted, "ovarian cancer is the most lethal of gynecologic cancers. The five-year survival rates are 40 percent. Only a few risk factors for ovarian cancer are modifiable."

The study included all Danish women (909,946) between the ages of 50 to 79 at the start of the study. During eight years of follow-up, the researchers found 3,068 cases of ovarian cancer. Of these, 2,681 were epithelial ovarian cancers.

As soon as women stopped taking hormones, the risk of ovarian cancer decreased. Women who had just stopped taking hormones compared to those who were off for les
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

0

GOOD

Page: 1 2 3

Related medicine news :

1. Asian spice could reduce breast cancer risk in women exposed to hormone replacement therapy
2. JNCI news brief: Breast cancer hormone receptor status and risk of a second primary tumor
3. Growth Hormone May Build Muscle in Older Men
4. Hormones May Affect Neurological Disease Risk
5. Hormone Could Improve Diabetes Treatment
6. Appetite-stimulating hormone is first potential medical treatment for frailty in older women
7. MORE WOMEN SHUN HORMONE REPLACEMENT THERAPY Garden of Life Offers a Natural Solution with Oceans 3™ Healthy Hormones™
8. Longer Hormone Treatment May Improve Prostate Cancer Outlook
9. Hormone therapy may confer more aggressive properties to prostate tumors
10. Pausing Hormone Therapy Doesnt Cut Mammogram Recalls
11. Fighting "Brain Fog": How the Right Hormones Can Improve Mental Sharpness for Women
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hormone Therapy Increases Odds of Ovarian Cancer
Hormone Therapy Increases Odds of Ovarian Cancer
Breaking Medicine News(10 mins):Health News:BioVeda Health and Wellness Center of Spring Hill, TN Announces Its Grand Opening 2Health News:BioVeda Health and Wellness Center of Spring Hill, TN Announces Its Grand Opening 3Health News:BioVeda Health and Wellness Center of Spring Hill, TN Announces Its Grand Opening 4Health News:BioVeda Health and Wellness Center of Spring Hill, TN Announces Its Grand Opening 5Health News:Centene Corporation to Provide 2010 Financial Guidance On January 8, 2010 2Health News:Centene Corporation to Provide 2010 Financial Guidance On January 8, 2010 3Health News:TouchSurfaces.Org Launches Public Health Information Site for Advanced Disinfectant Solutions for Use Around Children and Pets 2Health News:TouchSurfaces.Org Launches Public Health Information Site for Advanced Disinfectant Solutions for Use Around Children and Pets 3Health News:Registered Dietitians Identify Diet 'Gaps' - and How to Handle Them 2Health News:Registered Dietitians Identify Diet 'Gaps' - and How to Handle Them 3Health News:The New York Eye and Ear Infirmary Announces Partnership with ZocDoc 2
Breaking Medicine Technology:OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 2OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 3OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 4Perceptive Informatics Introduces Greater Convergence Between EDC and RTSM Solutions in Its eClinical Suite 2Perceptive Informatics Introduces Greater Convergence Between EDC and RTSM Solutions in Its eClinical Suite 3Perceptive Informatics Introduces Greater Convergence Between EDC and RTSM Solutions in Its eClinical Suite 4Perceptive Informatics Introduces Greater Convergence Between EDC and RTSM Solutions in Its eClinical Suite 5Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 2Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 3Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 4Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 5Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 6Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 7Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 8Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 9Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 10Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 11Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 12Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 13Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 14Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 15Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 16Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 17Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 18Patients Taking VIMOVO 28TM 29 Showed a Decrease in Incidence of NSAID Associated Ulcers 5553 1Patients Taking VIMOVO 28TM 29 Showed a Decrease in Incidence of NSAID Associated Ulcers 5553 2Patients Taking VIMOVO 28TM 29 Showed a Decrease in Incidence of NSAID Associated Ulcers 5553 3Patients Taking VIMOVO 28TM 29 Showed a Decrease in Incidence of NSAID Associated Ulcers 5553 4Patients Taking VIMOVO 28TM 29 Showed a Decrease in Incidence of NSAID Associated Ulcers 5553 5PhRMA Statement Supporting Fair Incentives for Biologics Innovation 5550 1PhRMA Statement Supporting Fair Incentives for Biologics Innovation 5550 2PhRMA Statement Supporting Fair Incentives for Biologics Innovation 5550 3PhRMA Statement Supporting Fair Incentives for Biologics Innovation 5550 4PhRMA Statement Supporting Fair Incentives for Biologics Innovation 5550 5Lifeclinic to Engage People Over 50 in Utilizing Technology and Wellness at AARP 2009 Event and Expo 59738 1Lifeclinic to Engage People Over 50 in Utilizing Technology and Wellness at AARP 2009 Event and Expo 59738 2Lifeclinic to Engage People Over 50 in Utilizing Technology and Wellness at AARP 2009 Event and Expo 59738 3